ID   FABPI_RAT               Reviewed;         132 AA.
AC   P02693;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   24-JUL-2024, entry version 182.
DE   RecName: Full=Fatty acid-binding protein, intestinal;
DE   AltName: Full=Fatty acid-binding protein 2;
DE   AltName: Full=Intestinal-type fatty acid-binding protein;
DE            Short=I-FABP;
GN   Name=Fabp2; Synonyms=Fabpi;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], CLEAVAGE OF INITIATOR METHIONINE, AND
RP   ACETYLATION AT ALA-2.
RX   PubMed=6582489; DOI=10.1073/pnas.81.2.313;
RA   Alpers D.H., Strauss A.W., Ockner R.K., Bass N.M., Gordon J.I.;
RT   "Cloning of a cDNA encoding rat intestinal fatty acid binding protein.";
RL   Proc. Natl. Acad. Sci. U.S.A. 81:313-317(1984).
RN   [2]
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=3840724; DOI=10.1016/0009-3084(85)90063-5;
RA   Gordon J.I., Lowe J.B.;
RT   "Analyzing the structures, functions and evolution of two abundant
RT   gastrointestinal fatty acid binding proteins with recombinant DNA and
RT   computational techniques.";
RL   Chem. Phys. Lipids 38:137-158(1985).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-80.
RX   PubMed=2824476; DOI=10.1016/s0021-9258(18)47696-x;
RA   Sweetser D.A., Birkenmeier E.H., Klisak I.J., Zollman S., Sparkes R.S.,
RA   Mohandas T., Lusis A.J., Gordon J.I.;
RT   "The human and rodent intestinal fatty acid binding protein genes. A
RT   comparative analysis of their structure, expression, and linkage
RT   relationships.";
RL   J. Biol. Chem. 262:16060-16071(1987).
RN   [4]
RP   PROTEIN SEQUENCE OF 30-34, AND LIGAND-BINDING.
RX   PubMed=12809510; DOI=10.1021/bi020680d;
RA   Arighi C.N., Rossi J.P.F.C., Delfino J.M.;
RT   "Temperature-induced conformational switch in intestinal fatty acid binding
RT   protein (IFABP) revealing an alternative mode for ligand binding.";
RL   Biochemistry 42:7539-7551(2003).
RN   [5]
RP   TISSUE SPECIFICITY, AND INDUCTION BY PEPTIDE YY.
RX   PubMed=9139712; DOI=10.1074/jbc.272.19.12591;
RA   Hallden G., Aponte G.W.;
RT   "Evidence for a role of the gut hormone PYY in the regulation of intestinal
RT   fatty acid-binding protein transcripts in differentiated subpopulations of
RT   intestinal epithelial cell hybrids.";
RL   J. Biol. Chem. 272:12591-12600(1997).
RN   [6]
RP   MUTAGENESIS OF GLY-45; ASN-55; GLY-66; GLY-76; GLY-81; GLY-87; ASP-98;
RP   GLY-100; GLY-111 AND GLY-122.
RX   PubMed=10082380; DOI=10.1002/pro.5560070818;
RA   Kim K., Frieden C.;
RT   "Turn scanning by site-directed mutagenesis: application to the protein
RT   folding problem using the intestinal fatty acid binding protein.";
RL   Protein Sci. 7:1821-1828(1998).
RN   [7] {ECO:0007744|PDB:2IFB}
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) IN COMPLEX WITH PALMITATE.
RX   PubMed=2671390; DOI=10.1016/0022-2836(89)90392-6;
RA   Sacchettini J.C., Gordon J.I., Banaszak L.J.;
RT   "Crystal structure of rat intestinal fatty-acid-binding protein. Refinement
RT   and analysis of the Escherichia coli-derived protein with bound
RT   palmitate.";
RL   J. Mol. Biol. 208:327-339(1989).
RN   [8] {ECO:0007744|PDB:1IFB}
RP   X-RAY CRYSTALLOGRAPHY (1.96 ANGSTROMS).
RX   PubMed=2682622; DOI=10.1073/pnas.86.20.7736;
RA   Sacchettini J.C., Gordon J.I., Banaszak L.J.;
RT   "Refined apoprotein structure of rat intestinal fatty acid binding protein
RT   produced in Escherichia coli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 86:7736-7740(1989).
RN   [9] {ECO:0007744|PDB:1IFC}
RP   X-RAY CRYSTALLOGRAPHY (1.19 ANGSTROMS).
RX   PubMed=1740465; DOI=10.2210/pdb1ifc/pdb;
RA   Scapin G., Gordon J.I., Sacchettini J.C.;
RT   "Refinement of the structure of recombinant rat intestinal fatty acid-
RT   binding apoprotein at 1.2-A resolution.";
RL   J. Biol. Chem. 267:4253-4269(1992).
RN   [10] {ECO:0007744|PDB:1ICM, ECO:0007744|PDB:1ICN}
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) IN COMPLEX WITH MYRISTATE.
RX   PubMed=8253762; DOI=10.1016/s0021-9258(19)74325-7;
RA   Eads J., Sacchettini J.C., Kromminga A., Gordon J.I.;
RT   "Escherichia coli-derived rat intestinal fatty acid binding protein with
RT   bound myristate at 1.5 A resolution and I-FABP Arg106-->Gln with bound
RT   oleate at 1.74 A resolution.";
RL   J. Biol. Chem. 268:26375-26385(1993).
RN   [11]
RP   STRUCTURE BY NMR.
RX   PubMed=9063893; DOI=10.1021/bi961890r;
RA   Hodsdon M.E., Cistola D.P.;
RT   "Discrete backbone disorder in the nuclear magnetic resonance structure of
RT   apo intestinal fatty acid-binding protein: implications for the mechanism
RT   of ligand entry.";
RL   Biochemistry 36:1450-1460(1997).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS), AND MUTAGENESIS OF VAL-61.
RX   PubMed=10692339; DOI=10.1016/s0006-3495(00)76707-5;
RA   Ropson I.J., Yowler B.C., Dalessio P.M., Banaszak L., Thompson J.;
RT   "Properties and crystal structure of a beta-barrel folding mutant.";
RL   Biophys. J. 78:1551-1560(2000).
CC   -!- FUNCTION: FABPs are thought to play a role in the intracellular
CC       transport of long-chain fatty acids and their acyl-CoA esters. FABP2 is
CC       probably involved in triglyceride-rich lipoprotein synthesis. Binds
CC       saturated long-chain fatty acids with a high affinity, but binds with a
CC       lower affinity to unsaturated long-chain fatty acids. FABP2 may also
CC       help maintain energy homeostasis by functioning as a lipid sensor (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- TISSUE SPECIFICITY: Expressed in the small intestine. Expression in the
CC       mucosal cells of the ileum extends from the midvillar region to the
CC       villus tips. {ECO:0000269|PubMed:9139712}.
CC   -!- INDUCTION: By peptide YY. {ECO:0000269|PubMed:9139712}.
CC   -!- DOMAIN: Forms a beta-barrel structure that accommodates the hydrophobic
CC       ligand in its interior.
CC   -!- SIMILARITY: Belongs to the calycin superfamily. Fatty-acid binding
CC       protein (FABP) family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; K01180; AAA41138.1; -; mRNA.
DR   EMBL; M35992; AAA41141.1; -; mRNA.
DR   EMBL; M18080; AAA41133.1; -; Genomic_DNA.
DR   PIR; I65761; FZRTI.
DR   RefSeq; NP_037200.1; NM_013068.1.
DR   PDB; 1A57; NMR; -; A=2-132.
DR   PDB; 1AEL; NMR; -; A=2-132.
DR   PDB; 1DC9; X-ray; 2.10 A; A=2-132.
DR   PDB; 1ICM; X-ray; 1.50 A; A=2-132.
DR   PDB; 1ICN; X-ray; 1.74 A; A=2-132.
DR   PDB; 1IFB; X-ray; 1.96 A; A=2-132.
DR   PDB; 1IFC; X-ray; 1.19 A; A=1-132.
DR   PDB; 1SA8; NMR; -; A=2-9, A=37-132.
DR   PDB; 1T8V; NMR; -; A=2-132.
DR   PDB; 1URE; NMR; -; A=2-132.
DR   PDB; 2IFB; X-ray; 2.00 A; A=2-132.
DR   PDB; 3AKN; X-ray; 1.60 A; A=2-132.
DR   PDBsum; 1A57; -.
DR   PDBsum; 1AEL; -.
DR   PDBsum; 1DC9; -.
DR   PDBsum; 1ICM; -.
DR   PDBsum; 1ICN; -.
DR   PDBsum; 1IFB; -.
DR   PDBsum; 1IFC; -.
DR   PDBsum; 1SA8; -.
DR   PDBsum; 1T8V; -.
DR   PDBsum; 1URE; -.
DR   PDBsum; 2IFB; -.
DR   PDBsum; 3AKN; -.
DR   AlphaFoldDB; P02693; -.
DR   BMRB; P02693; -.
DR   SMR; P02693; -.
DR   STRING; 10116.ENSRNOP00000030244; -.
DR   iPTMnet; P02693; -.
DR   PhosphoSitePlus; P02693; -.
DR   PaxDb; 10116-ENSRNOP00000030244; -.
DR   DNASU; 25598; -.
DR   Ensembl; ENSRNOT00000101450.1; ENSRNOP00000093186.1; ENSRNOG00000024947.4.
DR   Ensembl; ENSRNOT00055047162; ENSRNOP00055038779; ENSRNOG00055027265.
DR   Ensembl; ENSRNOT00060004645; ENSRNOP00060003316; ENSRNOG00060002871.
DR   Ensembl; ENSRNOT00065037350; ENSRNOP00065030152; ENSRNOG00065021935.
DR   GeneID; 25598; -.
DR   KEGG; rno:25598; -.
DR   UCSC; RGD:2591; rat.
DR   AGR; RGD:2591; -.
DR   CTD; 2169; -.
DR   RGD; 2591; Fabp2.
DR   eggNOG; KOG4015; Eukaryota.
DR   GeneTree; ENSGT00800000124172; -.
DR   InParanoid; P02693; -.
DR   OrthoDB; 2946847at2759; -.
DR   PhylomeDB; P02693; -.
DR   TreeFam; TF316894; -.
DR   Reactome; R-RNO-163560; Triglyceride catabolism.
DR   EvolutionaryTrace; P02693; -.
DR   PRO; PR:P02693; -.
DR   Proteomes; UP000002494; Chromosome 2.
DR   GO; GO:0045179; C:apical cortex; IDA:RGD.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0005902; C:microvillus; IDA:RGD.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005504; F:fatty acid binding; IDA:RGD.
DR   GO; GO:0036041; F:long-chain fatty acid binding; IDA:CAFA.
DR   GO; GO:0005324; F:long-chain fatty acid transmembrane transporter activity; IDA:RGD.
DR   GO; GO:0006631; P:fatty acid metabolic process; IDA:RGD.
DR   GO; GO:0015908; P:fatty acid transport; IEP:RGD.
DR   GO; GO:0050892; P:intestinal absorption; IDA:RGD.
DR   GO; GO:0098856; P:intestinal lipid absorption; ISO:RGD.
DR   GO; GO:0015909; P:long-chain fatty acid transport; IDA:RGD.
DR   CDD; cd19445; FABP2; 1.
DR   Gene3D; 2.40.128.20; -; 1.
DR   InterPro; IPR012674; Calycin.
DR   InterPro; IPR031272; FABP2.
DR   InterPro; IPR000463; Fatty_acid-bd.
DR   InterPro; IPR031259; ILBP.
DR   InterPro; IPR000566; Lipocln_cytosolic_FA-bd_dom.
DR   PANTHER; PTHR11955; FATTY ACID BINDING PROTEIN; 1.
DR   PANTHER; PTHR11955:SF89; FATTY ACID-BINDING PROTEIN, INTESTINAL; 1.
DR   Pfam; PF00061; Lipocalin; 1.
DR   PRINTS; PR00178; FATTYACIDBP.
DR   SUPFAM; SSF50814; Lipocalins; 1.
DR   PROSITE; PS00214; FABP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cytoplasm; Direct protein sequencing;
KW   Lipid-binding; Reference proteome; Transport.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:6582489"
FT   CHAIN           2..132
FT                   /note="Fatty acid-binding protein, intestinal"
FT                   /id="PRO_0000067330"
FT   BINDING         83
FT                   /ligand="hexadecanoate"
FT                   /ligand_id="ChEBI:CHEBI:7896"
FT                   /evidence="ECO:0000269|PubMed:2671390,
FT                   ECO:0007744|PDB:2IFB"
FT   BINDING         83
FT                   /ligand="tetradecanoate"
FT                   /ligand_id="ChEBI:CHEBI:30807"
FT                   /evidence="ECO:0000269|PubMed:8253762,
FT                   ECO:0007744|PDB:1ICM"
FT   BINDING         107
FT                   /ligand="hexadecanoate"
FT                   /ligand_id="ChEBI:CHEBI:7896"
FT                   /evidence="ECO:0000269|PubMed:2671390,
FT                   ECO:0007744|PDB:2IFB"
FT   BINDING         107
FT                   /ligand="tetradecanoate"
FT                   /ligand_id="ChEBI:CHEBI:30807"
FT                   /evidence="ECO:0000269|PubMed:8253762,
FT                   ECO:0007744|PDB:1ICM"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000269|PubMed:6582489"
FT   MUTAGEN         45
FT                   /note="G->V: Small reduction in stability, impaired ligand
FT                   binding."
FT                   /evidence="ECO:0000269|PubMed:10082380"
FT   MUTAGEN         55
FT                   /note="N->V: No reduction in stability."
FT                   /evidence="ECO:0000269|PubMed:10082380"
FT   MUTAGEN         61
FT                   /note="V->N: Reduced thermodynamic stability."
FT                   /evidence="ECO:0000269|PubMed:10692339"
FT   MUTAGEN         66
FT                   /note="G->V: Large reduction in stability."
FT                   /evidence="ECO:0000269|PubMed:10082380"
FT   MUTAGEN         76
FT                   /note="G->V: Reduced stability."
FT                   /evidence="ECO:0000269|PubMed:10082380"
FT   MUTAGEN         81
FT                   /note="G->V: Large reduction in stability."
FT                   /evidence="ECO:0000269|PubMed:10082380"
FT   MUTAGEN         87
FT                   /note="G->V: No reduction in stability, impaired ligand
FT                   binding."
FT                   /evidence="ECO:0000269|PubMed:10082380"
FT   MUTAGEN         98
FT                   /note="D->V: Reduced stability."
FT                   /evidence="ECO:0000269|PubMed:10082380"
FT   MUTAGEN         100
FT                   /note="G->V: Large reduction in stability."
FT                   /evidence="ECO:0000269|PubMed:10082380"
FT   MUTAGEN         111
FT                   /note="G->V: Small reduction in stability, impaired ligand
FT                   binding."
FT                   /evidence="ECO:0000269|PubMed:10082380"
FT   MUTAGEN         122
FT                   /note="G->V: Large reduction in stability."
FT                   /evidence="ECO:0000269|PubMed:10082380"
FT   CONFLICT        10
FT                   /note="D -> Y (in Ref. 1; AAA41138)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        83
FT                   /note="W -> L (in Ref. 1; AAA41138)"
FT                   /evidence="ECO:0000305"
FT   STRAND          5..14
FT                   /evidence="ECO:0007829|PDB:1IFC"
FT   HELIX           15..22
FT                   /evidence="ECO:0007829|PDB:1IFC"
FT   HELIX           26..32
FT                   /evidence="ECO:0007829|PDB:1IFC"
FT   STRAND          38..44
FT                   /evidence="ECO:0007829|PDB:1IFC"
FT   STRAND          47..53
FT                   /evidence="ECO:0007829|PDB:1IFC"
FT   STRAND          55..57
FT                   /evidence="ECO:0007829|PDB:1AEL"
FT   STRAND          58..64
FT                   /evidence="ECO:0007829|PDB:1IFC"
FT   STRAND          69..72
FT                   /evidence="ECO:0007829|PDB:1IFC"
FT   STRAND          73..76
FT                   /evidence="ECO:0007829|PDB:1A57"
FT   STRAND          78..86
FT                   /evidence="ECO:0007829|PDB:1IFC"
FT   STRAND          89..96
FT                   /evidence="ECO:0007829|PDB:1IFC"
FT   TURN            97..99
FT                   /evidence="ECO:0007829|PDB:1IFC"
FT   STRAND          102..110
FT                   /evidence="ECO:0007829|PDB:1IFC"
FT   STRAND          113..120
FT                   /evidence="ECO:0007829|PDB:1IFC"
FT   STRAND          123..131
FT                   /evidence="ECO:0007829|PDB:1IFC"
SQ   SEQUENCE   132 AA;  15124 MW;  A652B8494FE8A71E CRC64;
     MAFDGTWKVD RNENYEKFME KMGINVVKRK LGAHDNLKLT ITQEGNKFTV KESSNFRNID
     VVFELGVDFA YSLADGTELT GTWTMEGNKL VGKFKRVDNG KELIAVREIS GNELIQTYTY
     EGVEAKRIFK KE
//
